Davis George Eric's Form 4 filing
Biomarin Pharmaceutical Inc (BMRN) · filed May 4, 2022
- Accession no.
- 0001567619-22-009494
- Filed
- May 4, 2022
- Trade date
- Apr 29-May 2, 2022
- Filing delay
- 5 daysLate
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 3 non-derivative transactions and 1 derivative transaction. Open-market sales total $1.23M. It was filed 5 days after the trade, past the 2-business-day deadline.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Davis George EricCIK 0001380710 | Officer (EVP, Chief Legal Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Apr 29, 2022 | Common Stock | AGrant or awardAcquired | +341 | $62.41 | +$21,281.81 | 66,339 | Direct | |
| May 2, 2022 | Common Stock | MOption exerciseAcquired | +15,347 | $37.46 | +$574,898.62 | 81,686 | Direct | |
| May 2, 2022 | Common Stock | SSaleDisposed | −15,347 | $80.38 | −$1,233,591.86 | 66,339 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| May 2, 2022 | Common Stock | MOption exerciseDisposed | −15,347 | $0.00 | $0 | 0 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
No transaction price on this filing refers to a footnote.